SII Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-17,406
Closed -$1.24M 117
2017
Q4
$1.24M Sell
17,406
-18,104
-51% -$1.37M 0.13% 128
2017
Q3
$2.87M Buy
35,510
+783
+2% +$59.9K 0.16% 115
2017
Q2
$2.46M Buy
34,727
+4,083
+13% +$272K 0.15% 126
2017
Q1
$2.08M Buy
30,644
+3,231
+12% +$227K 0.14% 124
2016
Q4
$1.96M Buy
27,413
+1,281
+5% +$95.2K 0.15% 121
2016
Q3
$2.07M Sell
26,132
-11,975
-31% -$973K 0.16% 114
2016
Q2
$3.19M Sell
38,107
-1,950
-5% -$173K 0.26% 84
2016
Q1
$3.68M Buy
40,057
+1,601
+4% +$144K 0.35% 71
2015
Q4
$3.89M Buy
38,456
+869
+2% +$90.4K 0.49% 46
2015
Q3
$3.69M Buy
37,587
+2,297
+7% +$255K 0.42% 59
2015
Q2
$4.14M Buy
35,290
+3,420
+11% +$374K 0.49% 47
2015
Q1
$3.13M Buy
31,870
+1,893
+6% +$192K 0.38% 67
2014
Q4
$2.82M Buy
29,977
+1,907
+7% +$197K 0.37% 65
2014
Q3
$2.99M Buy
28,070
+17,925
+177% +$1.76M 0.4% 66
2014
Q2
$836K Buy
10,145
+1,646
+19% +$128K 0.12% 185
2014
Q1
$644K Buy
8,499
+1,726
+25% +$135K 0.12% 190
2013
Q4
$514K Buy
6,773
+685
+11% +$47.7K 0.09% 232
2013
Q3
$381K Sell
6,088
-170
-3% -$10.2K 0.09% 220
2013
Q2
$323K Buy
+6,258
New +$326K 0.07% 268

Other funds holding GILD

SII Investments's GILD Position: Q1 2018 in Review

SII Investments sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 17,406 shares — an estimated $1.24M sold.

SII Investments first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $4.14M in Q2 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • SII Investments reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 17,406 Gilead Sciences shares in Q1 2018, an estimated $1.24M.
  • SII Investments first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
  • SII Investments's Gilead Sciences position peaked at $4.14M in Q2 2015.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.